Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 20/20 | 0.78 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.67 |
| ▸ | MAP3K6 | O95382 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23631287 | 0.92 | MAP3K5 (0.79) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL29624545 | 0.92 | MAP3K5 (0.79) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL20523512 | 0.91 | MAP3K5 (0.70) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL20523643 | 0.89 | MAP3K5 (0.69) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL29624541 | 0.89 | MAP3K5 (0.69) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL29624631 | 0.89 | MAP3K5 (0.80) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL29624589 | 0.88 | MAP3K5 (0.80) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL23631229 | 0.88 | MAP3K5 (0.80) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL23631268 | 0.87 | MAP3K5 (0.74) | MAP3K5MAP3K7MAP3K6 | |
| SCHEMBL29624562 | 0.87 | MAP3K5 (0.74) | MAP3K5MAP3K7MAP3K6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345676-B2 | Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds | PHARMAKEA, INC. (US) | 2022-05-31 | — | — | US | claimed |
| US-11345676-B2 | Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds | PHARMAKEA, INC. (US) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345676-B2 | Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds | BAX, BAD, BCL2 | MAP3K5 13/4885MAP3K7 16/4885MAP3K6 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.